Sara Federico

Trials

Studies that name Sara Federico as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:24 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07502066 · Clinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological Diseases

  IRCCS San Camillo, Venezia, Italy · active not recruiting · Multiple Sclerosis, Parkinson Disease · principal investigator
• Ph2
  NCT07085338 · A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

  St. Jude Children's Research Hospital · recruiting · Neuroblastoma Recurrent · principal investigator
• N/A
  NCT06480526 · Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

  St. Jude Children's Research Hospital · active not recruiting · High-risk Neuroblastoma · principal investigator
• Ph1/Ph2
  NCT04901702 · Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  St. Jude Children's Research Hospital · recruiting · Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma · principal investigator
• Ph1
  NCT00665990 · Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia

  St. Jude Children's Research Hospital · completed · Refractory Solid Tumors, Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.